Board

greg

Greg Collier, PhD

Co-founder and Executive Chairman

Dr Collier has more than 25 years experience spanning commercial, operational, clinical and scientific aspects of pharmaceutical research and development. He is a highly regarded and successful biotechnology senior executive with an outstanding international record of achievement in clinical drug development, corporate management, strategic planning and implementation across the global biotechnology industry.

He has held positions of CEO, Executive Chairman, Director and Non-Executive Director at ChemGenex Pharmaceuticals, Invion Limited, Photonz Corp, Avecho Ltd, Tessara Ltd and other start up biotechnology companies. His experience in pre-clinical and clinical drug development is complemented with extensive experience in technology commercialisation, strategic planning, deal negotiation and transaction such as licensing, M&A and trade sales. In 2013 Greg was a co-founder of Evolve Biosystems, a leading US-based infant probiotics company.

Geoff

Geoff Brooke, MBBS, MBA

Independent Non Executive Director

Dr Geoff Brooke has over 30 years of healthcare investment experience, founding and leading venture capital firms in both the US and Australia. Geoff’s experience includes company formation and acquisitions, as well as public listings on the NYSE, NASDAQ and ASX exchanges. He has been a founder, executive, director and chairman of private and public companies and has an extensive international network. Geoff now works with a number of Australian and US companies, helping them reach their full potential. From 2009 until 2015, he was an independent director of the Victoria Workcover Authority (Worksafe).

Geoff is licensed in clinical medicine by the Medical Board of Victoria, Australia, and his post-graduate work was in anaesthetics/intensive care. He earned his Bachelor of Medicine/Surgery from the University of Melbourne, Australia, and a Masters of Business Administration from IMEDE (now IMD) in Lausanne, Switzerland.

Shari

Shari Lofthouse, PhD, MBA

Non Executive Director

Shari is Senior Business Development Manager at Murdoch Children’s Research Institute, where she oversees the Biotech/Medtech portfolio for the Institute; the largest child health research institute in Australia and one of the top 3 worldwide. Shari has over twenty years of experience in academic technology transfer, research contracts and intellectual property, as well as industry experience in vaccine development and drug delivery technologies.

Shari holds a PhD from the University of Melbourne, an MBA from Edinburgh Business School, and is a Graduate of the Australian Institute of Company Directors.